Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Thomson, Benjamin K A ^a   MacRae, Jennifer M ^a   Barnieh, Lianne ^a   Zhang, Jianguo ^a   MacKay, Elizabeth ^a   Manning, Megan A ^a   Hemmelgarn, Brenda R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anticoagulation; Hemodialysis; Warfarin nomogram

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED STUDY; ELECTRONIC ANTICOAGULATION NOMOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; NURSE; OUTPATIENT; PHYSICIAN; THROMBOEMBOLISM; THROMBOSIS; AMBULATORY CARE; CHRONIC KIDNEY FAILURE; DRUG ADMINISTRATION; ELECTRONIC MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; NURSING; NURSING DISCIPLINE; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SPECIALTIES, NURSING; THROMBOSIS; WARFARIN;

EID: 80053374880     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-46     Document Type: Article

References (33)

1. The pharmacology and management of the Vitamin K antagonists: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E, Chest 2004 126 204 233 10.1378/chest.126.3-suppl.204S
2. Risk factors for intracranial hemorage in outpatients taking warfarin. Hylek E, Skates S, Sheehan M, Singer D, Ann Intern Med 1994 120 897 902 8172435 (Pubitemid 24179151)
3. Elevated risk of stroke among patients with end-stage renal disease. Seliger G, Gillen D, Longstreth WJ, Kestenbaum B, Stehman-Breen C, Kidney Int 2003 64 603 609 10.1046/j.1523-1755.2003.00101.x 12846756 (Pubitemid 36871932)
4. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T, Am J Kidney Dis 1998 31 991 996 10.1053/ajkd.1998.v31. pm9631844 9631844 (Pubitemid 28265196)
5. Major bleeding in hemodialysis patients. Holden R, Harman G, Wang M, Holland D, Day A, Clin J Am Soc Nephrol 2008 3 105 110 10.2215/CJN.01810407 18003768
6. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Elliott M, Zimmerman D, Holden R, Am J Kidney Dis 2007 50 433 440 10.1053/j.ajkd.2007.06.017 17720522 (Pubitemid 47285456)
7. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. Chan K, Lazarus J, Thadhani R, Hakim R, J Am Soc Nephrol 2009 20 872 881 10.1681/ASN.2008080824 19297555
8. A standard heparin nomogram for the management of heparin therapy. Cruickshank M, Levine M, Hirsh J, Roberts R, Siguenza M, Arch Intern Med 1991 151 333 337 10.1001/archinte.151.2.333 1789820
9. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit. Brown G, Dodek P, Crit Care Med 1997 25 1534 1538 10.1097/00003246-199709000-00021 9295828 (Pubitemid 27391483)
10. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. Donovan J, Drake J, Whittaker P, Tran M, J Thromb Thrombolysis 2006 22 23 30 10.1007/s11239-006- 8328-9 16786229 (Pubitemid 43922998)
11. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Ellis R, Stephens M, Sharp G, Am J Hosp Pharm 1992 49 387 394 1554003
12. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic. Bussey H, Rospond R, Quandt C, Clark G, Pharmacotherapy 1989 9 214 219 2788876 (Pubitemid 19229528)
13. Evaluation of a pharmacist-managed anticoagulation clinic. Cohen I, Hutchison T, Kirking D, Shue M, J Clin Hosp Pharm 1985 10 167 175 4019790 (Pubitemid 15059882)
14. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Cromheecke M, Levi M, Colly L, de Mol B, Prins M, Hutten B, Mark R, Keyzers K, Buller H, Lancet 2000 356 97 102 10.1016/S0140-6736(00)02470-3 10963245 (Pubitemid 30438510)
15. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, Schwartz L, Fung A, Can J Cardiol 2004 20 1117 1123 15457308 (Pubitemid 39302738)
16. Self-management of oral anticoagulant therapy for mechanical heart valve patients. Christensen T, Atterman J, Pilegaard H, Andersen N, Maegaard M, Hasenkam J, Scand Cardiovasc J 2001 35 107 113 10.1080/140174301750164772 11405485 (Pubitemid 32447724)
17. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T, Thromb Haemost 1993 69 316 320 8497842 (Pubitemid 23103115)
18. Self management of oral anticoagulant therapy after heart valve replacement. Hasenkam J, Kimose H, Knudsen L, Gronnesby H, Halborg J, Christensen T, Atterman J, Pilegaard H, Eur J Cardiothorac Surg 1997 11 935 942 10.1016/S1010-7940(97)01204-9 9196312 (Pubitemid 27261896)
19. Improving management of atrial fibrillation and anticoagulation in a community hospital. Gaughan G, Dolan C, Wilk-Rivard E, Geary G, Libbey R, Gilman M, Lanata H, Jt Comm J Qual Improv 2000 26 18 28 10677819
20. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Heidinger K, Bernardo A, Taborski U, Muller-Berghaus G, Thromb Res 2000 98 287 293 10.1016/S0049-3848(00) 00181-X 10822075 (Pubitemid 30255932)
21. The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Manns B, Mortis G, Taub K, McLaughlin K, Donaldson C, Ghali W, Clin Invest Med 2001 24 164 170 11558850 (Pubitemid 32912362)
22. Pharmacology and Management of the Vitamin K antagonists. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Ansell J, Jirsh J, Hylek E, Jacobson A, Crowther A, Palareti G, Chest 2008 133 160S 190S 10.1378/chest.08-0670 18574265 (Pubitemid 351892967)
23. Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Bungard T, Gardner L, Archer S, Hamilton P, Ritchie B, Tymchak W, Tsuyuki R, Open Med 2009 3 16 21 19946388
24. Effect of study setting on anticoagulation control: a systematic review and metaregression. van Walraven C, Jennings A, Oake N, Fergusson D, Forster A, Chest 2006 129 1155 1166 10.1378/chest.129.5.1155 16685005
25. Pharmacokinetics and dialysability of warfarin in end-stage renal disease. Ifudu O, Dulin A, Nephron 1993 65 150 151 10.1159/000187458 8413775 (Pubitemid 23241557)
26. Vitamin K status of Canadian peritoneal dialysis patients. Holden R, Iliescu E, Morton A, Booth S, Perit Dial Int 2008 28 415-8
27. Guidelines on oral anticoagulation: third edition. Br J Maematol 1998 101 374 387
28. Warfarin for atrial fibrillation in community-based practice. Rose A, Ozonoff A, Henault L, Hylek E, J Thromb Haemost 2008 6 1647 1654 10.1111/j.1538-7836.2008.03075.x 18853483
29. Evaluation of INR monitoring frequency and time in therapeutic range. Snyder C, Helms B, Hall D, J Pharm Technol 2008 24 255 260
30. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Heneghan C, Alonso-Coelle P, Garcia-Alamino J, Perera R, Meats E, Glasziou P, Lancet 2006 367 404 411 10.1016/S0140-6736(06)68139-7 16458764 (Pubitemid 43184260)
31. Optimal frequency of patient monitoring and intensity of oral anticoagluation therapy in valvular heart disease. Horstkotte D, Piper C, Wiemer M, J Thromb Thrombolysis 2008 5 19 24
32. Incidence of stroke among chronic hemoidialysis patients with nonrheumatic atrial fibrillation. Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P, Am J Nephrol 2001 21 35 39 10.1159/000046216 11275630 (Pubitemid 32238611)
33. Treatment of End-Stage Organ Failure in Canada, 1999 to 2008-CORR 2010 Annual Report. Canadian Institute for Health Information, Ottawa, Ont 2010